会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 산화질소 생성 억제용 피라졸로피리미딘 유도체 화합물
    • 吡唑并嘧啶衍生物,抑制生产氮氧化物的组合物和药物组合物,用于预防和治疗包括其的疾病
    • KR1020130112248A
    • 2013-10-14
    • KR1020120034483
    • 2012-04-03
    • 한국과학기술연구원울산대학교 산학협력단
    • 정찬성김동진박기덕김윤경표정인김현태황온유아쉬라송치만김영수
    • C07D487/04A61K31/519A61P25/00
    • PURPOSE: A composition containing a pyrazolopyrimidine derivative compound for suppressing NO generation and a pharmaceutical composition containing the pyrazolopyrimidine derivative compound for preventing and treating neurological disorders are provided to suppress NO generation in vivo and to treat neurological disorders caused by functional disturbance and apoptosis of neural cells. CONSTITUTION: A pyrazolopyrimidine derivative compound of chemical formulas I-VII or a pharmaceutically acceptable salt thereof is provided. A pharmaceutical composition for suppressing NO generation contains a pharmaceutically acceptable carrier or diluent and the compounds as active ingredients. A composition for treating neurological disorders contains the pharmaceutically acceptable carrier or diluent and the compounds as active ingredients. The neurological diseases are selected among Parkinson's disease, Alzheimer's disease, Huntington's disease, amylotrophic lateral sclerosis, epilepsia, depression, pain, anxiety, and neurodegenerative diseases.
    • 目的:提供含有用于抑制NO产生的吡唑并嘧啶衍生物化合物和含有吡唑并嘧啶衍生物化合物用于预防和治疗神经障碍的药物组合物,用于抑制体内NO产生并治疗由神经细胞的功能紊乱和细胞凋亡引起的神经障碍 。 构成:提供化学式I-VII的吡唑并嘧啶衍生物化合物或其药学上可接受的盐。 用于抑制NO生成的药物组合物含有药学上可接受的载体或稀释剂,作为活性成分的化合物。 用于治疗神经障碍的组合物含有药学上可接受的载体或稀释剂,并且所述化合物作为活性成分。 神经系统疾病选自帕金森病,阿尔茨海默病,亨廷顿病,肌营养性侧索硬化,癫痫,抑郁,疼痛,焦虑和神经变性疾病。
    • 6. 发明授权
    • 호열성 리파제를 생산하는 균주
    • 호열성리파제를생산하는균주
    • KR100411236B1
    • 2003-12-18
    • KR1020000050149
    • 2000-08-28
    • 한국과학기술연구원
    • 신평균윤문영박호일정찬성한예선
    • C12N1/20
    • PURPOSE: Provided is a microorganism strain producing thermophile lipase. The above strain is obtained from the soil samples near the industrial complex, identified as a novel lipase producing strain different from known Burkholderia cepacia and named as SY-02(Burkholderia cepacia SY-02). It shows thermo-stability and high enzyme activity at the higher temperature than the melting point of fat and is thus widely useful as a lipase producing strain in the field of industry. CONSTITUTION: The strain Burkholderia cepacis SY-02(KFCC-111210) produces thermophilic lipase which is secreted into the exterior of a cell of Burkholderia cepacia SY-02, and shows activity at 40-80 deg.C, preferably 70 deg.C.
    • 目的:提供一种产生嗜热脂肪酶的微生物菌株。 上述菌株从工业园区附近的土壤样品中获得,鉴定为与已知洋葱伯克霍尔德菌不同的新型脂肪酶生产菌株,命名为SY-02(洋葱伯克霍尔德菌SY-02)。 它在高于脂肪熔点的温度下显示热稳定性和高酶活性,因此广泛用作工业领域中的脂肪酶生产菌株。 构成:菌株伯克霍尔德氏菌SY-02(KFCC-111210)产生分泌到洋葱伯克霍尔德氏菌SY-02细胞外部的嗜热性脂肪酶,并在40-80℃,优选70℃显示出活性。
    • 7. 发明授权
    • 라세미체의 케토로락을 단일이성체로 분리하는 방법
    • 라세미체의케토로락을단일이미지로분리하는방
    • KR100400885B1
    • 2003-10-17
    • KR1020010043741
    • 2001-07-20
    • 경동제약 주식회사한국과학기술연구원
    • 이병석정찬성이소하김영희
    • C07D487/04
    • PURPOSE: A separating method of a single isomer from the ketorolac of the racemic body is provided, thereby separating the high purity of a single isomer form ketorolac. CONSTITUTION: The separating method of a single isomer from the ketorolac of the racemic body comprises the steps of: reaction of the ketorolac of the racemic body represented by formula(1) with alcohol compounds in the presence of Candida antartica lipase B; and separation of (-)-isomer from the reaction mixture by absorption, wherein the alcohol compounds are C3 to C20 alcohols; the amount of the Candida antartica lipase B is 10 to 150 wt.%; and the reaction temperature is 20 to 70 deg. C.
    • 目的:提供从外消旋体的酮咯酸中分离单一异构体的方法,由此分离单一异构体形式的酮咯酸的高纯度。 构成:从外消旋体的酮咯酸中分离单一异构体的方法包括以下步骤:使由式(1)表示的外消旋体的酮咯酸与醇化合物在南极假丝酵母脂肪酶B存在下反应; 和通过吸收从反应混合物中分离( - ) - 异构体,其中醇化合物是C 3 -C 20醇; 南极假丝酵母脂肪酶B的量为10至150重量%; 反应温度为20〜70℃。 C。
    • 8. 发明授权
    • 광학활성을 갖는 부탄아마이드 유도체의 제조방법
    • 大学教育学院
    • KR100379755B1
    • 2003-04-11
    • KR1020000064693
    • 2000-11-01
    • 한국과학기술연구원
    • 정찬성이소하
    • C07C25/00
    • PURPOSE: A process for producing butanamides having optical activity is provided, thereby easily producing butanamides useful as an intermediate in manufacturing antimicrobial agents, herbicides or medicines, in higher yield. CONSTITUTION: The process for producing butanamides having optical activity comprises the steps of: resolving racemic 4-phenyl-3-(4-phenoxyphenyl) butanoic acid of formula(2) into (3R)-(+)-4-phenyl-3-(4-phenoxyphenyl) butanoic acid of formula(2a) and (3S)-(-)-4-phenyl-3-(4-phenoxyphenyl) butanoic acid of formula(2b) using R-(+)-methylbenzylamine of formula(3); and reacting each divided compound of formula(2a) or formula(2b) with aniline derivative of formula(5) to produce butanamide derivative of formula(1).
    • 目的:提供一种生产具有光学活性的丁酰胺的方法,由此容易以较高的收率制备可用作制备抗微生物剂,除草剂或药物的中间体的丁酰胺。 构成:具有光学活性的丁酰胺的制备方法包括以下步骤:将式(2)的外消旋4-苯基-3-(4-苯氧基苯基)丁酸转化为(3R) - (+) - 4-苯基-3- (+) - 甲基苄胺制备式(2a)的(4-苯氧基苯基)丁酸和(3S) - ( - ) - 4-苯基-3-(4-苯氧基苯基)丁酸 3); (2a)或式(2b)的每种分开的化合物与式(5)的苯胺衍生物反应以产生式(1)的丁酰胺衍生物。
    • 9. 发明公开
    • 광학활성을 갖는 부탄아마이드 유도체의 제조방법
    • 生产具有光活性的丁胺的方法
    • KR1020020034017A
    • 2002-05-08
    • KR1020000064693
    • 2000-11-01
    • 한국과학기술연구원
    • 정찬성이소하
    • C07C25/00
    • PURPOSE: A process for producing butanamides having optical activity is provided, thereby easily producing butanamides useful as an intermediate in manufacturing antimicrobial agents, herbicides or medicines, in higher yield. CONSTITUTION: The process for producing butanamides having optical activity comprises the steps of: resolving racemic 4-phenyl-3-(4-phenoxyphenyl) butanoic acid of formula(2) into (3R)-(+)-4-phenyl-3-(4-phenoxyphenyl) butanoic acid of formula(2a) and (3S)-(-)-4-phenyl-3-(4-phenoxyphenyl) butanoic acid of formula(2b) using R-(+)-methylbenzylamine of formula(3); and reacting each divided compound of formula(2a) or formula(2b) with aniline derivative of formula(5) to produce butanamide derivative of formula(1).
    • 目的:提供具有光学活性的丁酰胺的制造方法,从而容易地制造用作制造抗微生物剂,除草剂或药物中的较高产率的中间体的丁酰胺。 制备具有光学活性的丁酰胺的方法包括以下步骤:将式(2)的外消旋4-苯基-3-(4-苯氧基苯基)丁酸分解成(3R) - (+) - 4-苯基-3- 式(2a)的(4-苯氧基苯基)丁酸和式(2b)的(3S) - ( - ) - 4-苯基-3-(4-苯氧基苯基)丁酸使用式 3); 并使式(2a)或式(2b)的每一个分开的化合物与式(5)的苯胺衍生物反应得到式(1)的丁酰胺衍生物。
    • 10. 发明授权
    • 1, 2-디아릴-1-에탄올 유도체를 함유하는 제초제
    • 1,2-二偶氮-1-乙醇衍生物
    • KR100242791B1
    • 2000-02-01
    • KR1019970021688
    • 1997-05-29
    • 한국과학기술연구원
    • 김인오정찬성이상기이소하
    • C07C33/24C07C29/159
    • 본 발명은 제초제로서 약효가 우수한 일반식(I)의 신규한 1,2-디아릴-1-에탄올 유도체에 관한 것으로 이의 제조방법은 일반식(II)의 아세틸 클로라이드 유도체와 일반식(III)의 벤젠유도체를 프리델-크라프트의 아실화 반응으로 일반식(IV)의 케톤화합물을 제조하고, 이를 환원시켜 제조하는 것이다.

      일반식(I)에 있어서, X와 Y는 각각 C
      1 ~C
      4 의 알킬, 또는 할로겐이거나, -NO
      2 ,-CN 또는 -CF
      3 로서 전자를 끄는 그룹 및 메톡시, 페녹시, 페닐, -OH 또는 -NH
      2 로서 페닐기의 오르토, 메타 또는 파라 위치에 치환되며, 일반식(II)에 있어서, R
      1 은 수소, 브롬 또는 불소를 나타내며, R
      2 는 수소 또는 불소를 나타내고 R
      3 는 수소, 불소 또는 염소를 나타내며, 일반식(III)에 있어서, R
      4 는 메틸, 메톡시, 브롬, 불소, 페녹시 또는 파라-브로모페닐기를 나타내며, R
      5 는 수소를 나타내고, 일반식(IV)에 있어서, R
      1 , R
      2 , 및 ,R
      3 는 일반식(III)에서와 동일하며, R
      5 는 수소를 나타낸다.